Avacta and Selexis partner to develop cell line for clinical manufacturing
GENEVA: Avacta Group plc, the developer of Affimer® biotherapeutics and research reagents, and Selexis, a pioneering life sciences company and global leader in mammalian cell line generation technology, have partnered…